Cargando…

Primary caregiver decision-making in hematopoietic cell transplantation and gene therapy for sickle cell disease

BACKGROUND: Improved outcomes and the availability of clinical trials of hematopoietic cell transplantation (HCT) from alternate donors and genetically modified autologous hematopoietic progenitor cells have expanded the applicability of HCT for sickle cell disease (SCD). To understand the perspecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sinha, Cynthia B., Bakshi, Nitya, Ross, Diana, Loewenstein, George, Krishnamurti, Lakshmanan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246626/ https://www.ncbi.nlm.nih.gov/pubmed/33034129 http://dx.doi.org/10.1002/pbc.28749

Ejemplares similares

Assessment of Patient and Caregiver Attitudes and Approaches to Decision-Making Regarding Bone Marrow Transplant for Sickle Cell Disease: A Qualitative Study
por: Bakshi, Nitya, et al.
Publicado: (2020)

A Decision Support Tool for Allogeneic Hematopoietic Stem Cell Transplantation for Children With Sickle Cell Disease: Acceptability and Usability Study
por: Veludhandi, Anirudh, et al.
Publicado: (2021)

Proponent or collaborative: Physician perspectives and approaches to disease modifying therapies in sickle cell disease
por: Bakshi, Nitya, et al.
Publicado: (2017)

Management of Chronic Pain in Adults Living With Sickle Cell Disease in the Era of the Opioid Epidemic: A Qualitative Study
por: Sinha, Cynthia B., et al.
Publicado: (2019)

From trust to skepticism: An in-depth analysis across age groups of adults with sickle cell disease on their perspectives regarding hydroxyurea
por: Sinha, Cynthia B., et al.
Publicado: (2018)

Decision-making about gene therapy in transfusion dependent thalassemia
por: Quarmyne, Maa-Ohui, et al.
Publicado: (2022)

Hydroxyurea therapy for children with sickle cell disease: describing how caregivers make this decision
por: Creary, Susan, et al.
Publicado: (2015)

Hematopoietic Cell Transplantation for Sickle Cell Disease
por: Krishnamurti, Lakshmanan
Publicado: (2021)

Presence of pain on three or more days of the week is associated with worse patient reported outcomes in adults with sickle cell disease
por: Bakshi, Nitya, et al.
Publicado: (2018)

Multimodal phenotyping and correlates of pain following hematopoietic cell transplant in children with sickle cell disease
por: Bakshi, Nitya, et al.
Publicado: (2023)

Acute Chest Syndrome in Children with Sickle Cell Disease
por: Jain, Shilpa, et al.
Publicado: (2017)

Patient and family experience with chronic transfusion therapy for sickle cell disease: A qualitative study
por: Hawkins, Lauren M., et al.
Publicado: (2020)

Comparative Effectiveness of a Web-Based Patient Decision Aid for Therapeutic Options for Sickle Cell Disease: Randomized Controlled Trial
por: Krishnamurti, Lakshmanan, et al.
Publicado: (2019)

Pain catastrophizing is associated with poorer health-related quality of life in pediatric patients with sickle cell disease
por: Bakshi, Nitya, et al.
Publicado: (2018)

Quantitative sensory testing is feasible and is well-tolerated in patients with sickle cell disease following a vaso-occlusive episode
por: Bakshi, Nitya, et al.
Publicado: (2018)

Intraindividual pain variability and phenotypes of pain in sickle cell disease: a secondary analysis from the Pain in Sickle Cell Epidemiology Study
por: Bakshi, Nitya, et al.
Publicado: (2022)

Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study
por: Krishnamurti, Lakshmanan, et al.
Publicado: (2022)

Mesenchymal stromal cells to modulate immune reconstitution early post-hematopoietic cell transplantation
por: Stenger, Elizabeth O., et al.
Publicado: (2015)

Sex and frequency of pain episodes are associated with acute pain trajectories in adolescents with sickle cell disease
por: Astles, Rachel, et al.
Publicado: (2023)

Assessing Patient Preferences for Treatment Options for Pediatric Sickle Cell Disease: A Critical Review of Quantitative and Qualitative Studies
por: Katoch, Deeksha, et al.
Publicado: (2021)

Effects of Music Therapy on Quality of Life in Adults with Sickle Cell Disease (MUSIQOLS): A Mixed Methods Feasibility Study
por: Rodgers-Melnick, Samuel N, et al.
Publicado: (2022)

The role of the arginine metabolome in pain: implications for sickle cell disease
por: Bakshi, Nitya, et al.
Publicado: (2016)

Thrombo-Inflammation in COVID-19 and Sickle Cell Disease: Two Faces of the Same Coin
por: Chiang, Kate Chander, et al.
Publicado: (2023)

Role of Comorbidities in Optimizing Decision-Making for Allogeneic Hematopoietic Cell Transplantation
por: Sorror, Mohamed L., et al.
Publicado: (2010)

Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in children
por: Schoettler, Michelle, et al.
Publicado: (2022)

Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases
por: Arnold, Staci D., et al.
Publicado: (2017)

Prevalence and predictors of chronic pain intensity and disability among adults with sickle cell disease
por: Matthie, Nadine, et al.
Publicado: (2020)

The hematopoietic saga of clonality in sickle cell disease
por: Stonestrom, Aaron J., et al.
Publicado: (2022)

Allogeneic Hematopoietic Stem Cell Transplantation for Adults with Sickle Cell Disease
por: Saraf, Santosh L., et al.
Publicado: (2019)

The perception of pediatric sickle cell anemia patient's caregivers toward hematopoietic stem cell transplantation (single-center experience, Saudi Arabia)
por: Monagel, Dania A., et al.
Publicado: (2023)

Hematopoietic Stem Cell Transplant for Sickle Cell Disease: PATIENT SELEction and Timing Based on Sickle Cell-Related Multiple Chronic Conditions
por: Jang, Tim, et al.
Publicado: (2021)

Hematopoietic Stem Cell Transplantation in Adult Sickle Cell Disease: Problems and Solutions
por: Özdoğu, Hakan, et al.
Publicado: (2015)

Hematopoietic stem cell transplantation in sickle cell disease: patient selection and special considerations
por: Bhatia, Monica, et al.
Publicado: (2015)

Allogeneic hematopoietic stem cell transplantation to cure sickle cell disease: A review
por: Bhalla, Nishka, et al.
Publicado: (2023)

Engaging Caregivers and Providers of Children With Sickle Cell Anemia in Shared Decision Making for Hydroxyurea: Protocol for a Multicenter Randomized Controlled Trial
por: Hood, Anna M, et al.
Publicado: (2021)

Education of Hematopoietic Stem Cell Transplant Caregivers in Preparation for Their Role
por: Metoyer, Lynora J.
Publicado: (2013)

Characterizing User Engagement With a Digital Intervention for Pain Self-management Among Youth With Sickle Cell Disease and Their Caregivers: Subanalysis of a Randomized Controlled Trial
por: Lalloo, Chitra, et al.
Publicado: (2022)

How to Facilitate Decision-Making for Hematopoietic Stem Cell Transplantation in Patients With Hemoglobinopathies. The Perspectives of Healthcare Professionals
por: Mekelenkamp, Hilda, et al.
Publicado: (2021)

Choice of Donor Source and Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Sickle Cell Disease
por: Limerick, Emily, et al.
Publicado: (2019)

Is There Any Improvement of the Coagulation Imbalance in Sickle Cell Disease after Hematopoietic Stem Cell Transplantation?
por: Rozen, Laurence, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k82qkeosi1us9lu61q8u9mcs46